Medical School: Christian Medical College, Ludhiana, India
Internship: Kingsbrook Jewish Medical Center, Brooklyn, NY
Residency: Kingsbrook Jewish Medical Center, Brooklyn, NY
Fellowship: University of Colorado, School of Medicine, Pulmonary/Critical Care Fellowship, Denver, CO
Dr. Antony is Professor of Medicine and the Director of the Adult Cystic Fibrosis Program at the University of Alabama at Birmingham (UAB). Dr. Antony's medical training began at Christian Medical College in Ludhiana, India. Following medical school, Dr. Antony progressed to an internship and residency at New York's Kingsbrook Jewish Medical Center. Following her Pulmonary and Critical Care Medicine Fellowship training in the University of Colorado's School of Medicine, Dr. Antony worked in Pulmonary Medicine at the University of Colorado Health Sciences Center, the Indiana University School of Medicine, and the University of Florida before beginning her work at UAB in 2010.
Dr. Antony’s research is focused on environmental and translational medicine, cystic fibrosis, pleural disease, and lung injury. Active studies involve work in the development of novel anti-fibrotic therapies, disease-relevant animal models of non-resolving fibrosism the role of HO-1 in protection against bromine-induced lung injury/fibrosis, and the infrastructure needed to support cystic fibrosis clinical trials.
Surolia R, Karki S, Kim H, Yu Z, Kulkarni T, Mirov SB, Carter AB, Rowe SM, Matalon S, Thannickal VJ, Agarwal A, Antony VB. Heme oxygenase-1-mediated autophagy protects against pulmonary endothelial cell death and development of emphysema in cadmium-treated mice. Am J Physiol Lung Cell Mol Physiol. 2015 Aug 1;309(3):L280-92. doi: 10.1152/ajplung.00097.2015. Epub 2015 Jun 12.
Li FJ, Duggal RN, Oliva OM, Karki S, Surolia R, Wang Z, Watson RD, Thannickal VJ, Powell M, Watts S, Kulkarni T, Batra H, Bolisetty S, Agarwal A, Antony VB. Heme oxygenase-1 protects corexit 9500A-induced respiratory epithelial injury across species. PLoS One. 2015 Apr 2;10(4):e0122275. doi: 10.1371/journal.pone.0122275. eCollection 2015.
Batra H, Antony VB. The pleural mesothelium in development and disease. Front Physiol. 2014 Aug 1;5:284. doi: 10.3389/fphys.2014.00284. eCollection 2014.
Karki S, Surolia R, Hock TD, Guroji P, Zolak JS, Duggal R, Ye T, Thannickal VJ, Antony VB. Wilms' tumor 1 (Wt1) regulates pleural mesothelial cell plasticity and transition into myofibroblasts in idiopathic pulmonary fibrosis. FASEB J. 2014 Mar;28(3):1122-31. doi: 10.1096/fj.13-236828. Epub 2013 Nov 21.
Zolak JS, Jagirdar R, Surolia R, Karki S, Oliva O, Hock T, Guroji P, Ding Q, Liu RM, Bolisetty S, Agarwal A, Thannickal VJ, Antony VB. Pleural mesothelial cell differentiation and invasion in fibrogenic lung injury. Am J Pathol. 2013 Apr;182(4):1239-47. doi: 10.1016/j.ajpath.2012.12.030. Epub 2013 Feb 9.
Regev D, Surolia R, Karki S, Zolak J, Montes-Worboys A, Oliva O, Guroji P, Saini V, Steyn AJ, Agarwal A, Antony VB. Heme oxygenase-1 promotes granuloma development and protects against dissemination of mycobacteria. Lab Invest. 2012 Nov;92(11):1541-52. doi: 10.1038/labinvest.2012.125. Epub 2012 Sep 10.
Mubarak KK, Montes-Worboys A, Regev D, Nasreen N, Mohammed KA, Faruqi I, Hensel E, Baz MA, Akindipe OA, Fernandez-Bussy S, Nathan SD, Antony VB. Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis. Eur Respir J. 2012 Jan;39(1):133-40. doi: 10.1183/09031936.00141010. Epub 2011 Jul 7.
Please click here for Dr. Antony's complete publications listing.